Forever Oceans is a FoodTech company that has pioneered a patented offshore aquaculture system based on proprietary technology to ocean-raise Omega-3-rich, Sashimi grade Forever Oceans Kanpachi fish.
QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and other diseases.
Conservation Easements are a great way to conserve property, reduce taxes, and create a lasting legacy for your family.
MAIA Biotechnology received preliminary data from its Phase 2 Clinical trial and the results are very promising.
Ispire is not a cannabis company. It is a technology company that makes hardware for cannabis consumers.
Force Family Office, Legacy Partners, and New York Private Bank & Trust reception and panel on how to execute a profitable exit and leave your mark for generations to come.
The Lumicell Direct Visualization System assists surgeons to detect cancerous tissue in real time so they can remove it all the first time.
All-natural energy drink is catching the eye of top pros as they look for healthier alternatives to Red Bull and other energy drinks.
Gain is ready to move into a Phase 1 clinical trials for with a novel small-molecule treatment for Parkinson’s disease.
Kineta, Inc. (Nasdaq: KA), announced today the achievement of a development milestone which triggers a $5 million payment from its research and development collaboration with Merck
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office